Rockey D C, Koch J, Cello J P, Sanders L L, McQuaid K
Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
N Engl J Med. 1998 Jul 16;339(3):153-9. doi: 10.1056/NEJM199807163390303.
Although bleeding lesions anywhere in the gastrointestinal tract can cause a positive reaction on guaiac-based fecal occult-blood tests, the relative frequency of upper gastrointestinal and colonic lesions is unknown.
During a period of 30 months, we prospectively studied all patients with at least one stool specimen containing fecal occult blood who were referred for further evaluation. Fecal occult blood was detected by standard guaiac-based tests of stool specimens obtained as part of routine screening or of stool obtained by digital rectal examination. Patients with documented iron-deficiency anemia or active gastrointestinal bleeding were excluded from the study. All participants had a detailed history taken and underwent colonoscopy, followed by esophagogastroduodenoscopy.
Of the 409 patients with fecal occult blood who were referred, 310 were potentially eligible to participate, and 248 (mean age, 61 years; range, 40 to 89) were studied; 40 percent were women. We identified lesions consistent with occult bleeding in 119 patients (48 percent); in 71 bleeding lesions were found in the upper gastrointestinal tract, and in 54 they were identified in the colon. Six patients had abnormalities in both areas. The most common upper gastrointestinal lesions were esophagitis (23 patients), gastric ulcer (14), gastritis (12), and duodenal ulcer (10). Thirty patients with lesions in the upper gastrointestinal tract were long-term users of aspirin, ethanol, nonsteroidal antiinflammatory drugs, or a combination of these substances. The most common colonic lesions were adenomas more than 1.0 cm in diameter (29 patients), carcinoma (13), colitis (5), and vascular ectasia (5). Although the overall sensitivity of symptoms for the detection of gastrointestinal lesions was low, logistic-regression analysis demonstrated that the presence of symptoms in the upper gastrointestinal tract was associated with the detection of lesions in the upper gastrointestinal tract (odds ratio, 2.6; 95 percent confidence interval, 1.4 to 4.7). In both patients with symptoms and those without symptoms, the prevalence of lesions in the upper gastrointestinal tract was greater than or equal to that of colonic lesions.
In a group of patients with positive fecal occult-blood tests who were referred for further evaluation, from which those with iron-deficiency anemia and active bleeding had been excluded, upper gastrointestinal lesions were identified more frequently than colonic lesions.
尽管胃肠道任何部位的出血性病变均可导致基于愈创木脂的粪便潜血试验呈阳性反应,但上消化道和结肠病变的相对发生率尚不清楚。
在30个月的时间里,我们对所有至少有一份粪便标本含潜血并被转诊以作进一步评估的患者进行了前瞻性研究。粪便潜血通过对作为常规筛查一部分获取的粪便标本或通过直肠指检获取的粪便进行标准的基于愈创木脂的试验来检测。有缺铁性贫血或活动性胃肠道出血记录的患者被排除在研究之外。所有参与者均详细记录病史并接受结肠镜检查,随后进行食管胃十二指肠镜检查。
在转诊的409例粪便潜血患者中,310例可能符合参与条件,对其中248例(平均年龄61岁,范围40至89岁)进行了研究;40%为女性。我们在119例患者(48%)中发现了与潜血一致的病变;71例在上消化道发现出血性病变,54例在结肠发现病变。6例患者在两个部位均有异常。最常见的上消化道病变为食管炎(23例)、胃溃疡(14例)、胃炎(12例)和十二指肠溃疡(10例)。30例上消化道有病变的患者为阿司匹林、乙醇、非甾体抗炎药或这些物质联合使用的长期使用者。最常见的结肠病变为直径大于1.0 cm的腺瘤(29例)、癌(13例)、结肠炎(5例)和血管扩张(5例)。尽管症状对检测胃肠道病变的总体敏感性较低,但逻辑回归分析表明,上消化道症状的存在与上消化道病变的检测相关(比值比,2.6;95%置信区间,1.4至4.7)。在有症状和无症状的患者中,上消化道病变的患病率均大于或等于结肠病变的患病率。
在一组粪便潜血试验呈阳性并被转诊作进一步评估的患者中,排除了缺铁性贫血和活动性出血患者后,上消化道病变的检出率高于结肠病变。